-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Named to China’s Most Influential Pharmaceutical Industry Rankings
Category:
发布时间：2023-07-05
【概要描述】
On July 3, the 15th China Pharmaceutical Industry Development Summit Forum, hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Harbin. During the event, the “2022–2023 List of the Most Influential Companies in China’s Pharmaceutical Industry” was unveiled, with Shijiazhuang Sihua Pharmaceutical Group honored as both a Top 100 Chinese Pharmaceutical Manufacturer and a Pioneer Enterprise for Independent Innovation in China’s Pharmaceutical Sector.
On July 3, the 15th China Pharmaceutical Industry Development Summit Forum, hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was held in Harbin. During the event, the “2022–2023 List of the Most Influential Companies in China’s Pharmaceutical Industry” was unveiled, with Shijiazhuang Sihua Pharmaceutical Group honored as both one of the Top 100 Chinese Pharmaceutical Manufacturers and a Pioneer Enterprise for Independent Innovation in China’s Pharmaceutical Sector.
In recent years, Shijiazhuang Sihua Pharmaceutical has seized development opportunities, strengthened its sense of responsibility and commitment, and, guided by the goal of ensuring smooth dual circulation in both domestic and international markets, accelerated forward-looking research and the building of scientific and technological innovation capabilities. By leveraging its comparative advantages and forging competitive strengths, the company has continuously extended, supplemented, and reinforced its industrial chains, thereby speeding up transformation and upgrading, further optimizing its industrial structure, and shifting its development model from scale-driven to innovation-driven. As a result, the company has demonstrated rapid and steady growth, achieving new breakthroughs in overall scale, product mix, and development quality, and reaping significant economic and social benefits.
According to reports, the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce launched the “Most Influential Ranking of China’s Pharmaceutical Industry” in 2014, and has since held the event for ten consecutive years. The ranking is based on a comprehensive set of criteria, including performance metrics, independent innovation capability, social responsibility index, and level of professionalization, and is conducted in collaboration with numerous well-known domestic media outlets. It is widely regarded as a leading indicator of trends in China’s pharmaceutical sector, accurately reflecting the overall pulse of industry development, and has garnered extensive attention from companies and business leaders across the sector. Leveraging its robust innovation capacity, strong brand strength, and outstanding operational performance, Shijiazhuang Sihua Pharmaceutical has repeatedly won multiple prestigious awards in this ranking over the years, thereby serving as an exemplary model and a key driver of high-quality development in the pharmaceutical industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091